Stevens-Johnson syndrome in children.

Area of Science:

• Pediatric Dermatology
• Cutaneous Adverse Reactions
• Immunology

Background:

• Stevens-Johnson syndrome (SJS) concept in pediatrics is evolving.
• SJS is often triggered by infections rather than medications.
• Traditional view places SJS on a spectrum with toxic epidermal necrolysis.

Purpose of the Study:

• Review recent advances in pediatric SJS.
• Integrate novel terminology: reactive infectious mucocutaneous eruption (RIME) and drug-induced epidermal necrolysis (DI-EN).
• Clarify distinctions between infection-triggered and drug-triggered blistering reactions.

Main Methods:

• Literature review of recent advances in pediatric SJS.
• Analysis of proposed pediatric-specific terminology.
• Comparison of clinical features and management based on triggers.

Main Results:

• Pediatric SJS is frequently infection-triggered.
• Novel terminology (RIME, DI-EN) offers practical application.
• Distinguishing triggers is crucial for accurate diagnosis and management.

Conclusions:

• Differentiating infection-triggered from drug-triggered reactions is clinically valuable.
• Early recognition of distinct features, like mucositis, is key.
• Accurate classification prevents mislabeling and guides appropriate initial management.